Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-24-035515

Options or other derivatives

  • Chief Executive Officer acquired 183,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kulkarni Samarth · Chief Executive Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-03-20 Grant or award : show line 1 in the form Stock Option (Right to Buy) +105,000 105,000 D
2024-03-20 Grant or award : show line 2 in the form Restricted Stock Units +78,750 78,750 D
Loading xslF345X05/ownership.xml…